Eton Pharmaceuticals Inc (ETON)
3.74
+0.09
(+2.47%)
USD |
NASDAQ |
May 02, 10:52
Eton Pharmaceuticals Cash from Operations (TTM): 6.815M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 6.815M |
September 30, 2023 | 9.268M |
June 30, 2023 | 6.692M |
March 31, 2023 | 2.05M |
December 31, 2022 | 4.821M |
September 30, 2022 | -3.136M |
June 30, 2022 | -4.383M |
March 31, 2022 | -7.213M |
December 31, 2021 | -4.721M |
September 30, 2021 | -6.786M |
June 30, 2021 | -8.93M |
Date | Value |
---|---|
March 31, 2021 | -11.41M |
December 31, 2020 | -22.35M |
September 30, 2020 | -19.01M |
June 30, 2020 | -17.13M |
March 31, 2020 | -18.48M |
December 31, 2019 | -18.03M |
September 30, 2019 | -15.95M |
June 30, 2019 | -15.03M |
March 31, 2019 | -13.06M |
December 31, 2018 | -8.145M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-22.35M
Minimum
Dec 2020
9.268M
Maximum
Sep 2023
-7.522M
Average
-7.213M
Median
Mar 2022
Cash from Operations (TTM) Benchmarks
Evoke Pharma Inc | -4.985M |
Outlook Therapeutics Inc | -47.10M |
NovaBay Pharmaceuticals Inc | -4.131M |
Palatin Technologies Inc | -26.54M |
iBio Inc | -18.89M |